Up to 15% weight loss.
Your first 12 weeks start here.

About 25–39% of total weight loss on a GLP-1 is lean mass, per the literature. With a protein-and-resistance plan (110+ g protein, two strength sessions/week), most members keep that closer to 15–20%. We won't pretend muscle loss isn't a thing; we just have a plan for it.

Per the STEP 4 trial, members who discontinued regained about 2/3 of lost weight within a year. The honest framing is that obesity is a chronic condition. Most members stay on a maintenance dose long-term. We design every plan with the off-ramp in mind so you understand the tradeoff.

Foundayo™ is orforglipron, an oral once-daily GLP-1, a different molecule from a different manufacturer, so no, it is not Ozempic. If you want an injectable, we prescribe the branded pens directly: Wegovy® (semaglutide) and Zepbound® (tirzepatide), fulfilled via NovoCare and LillyDirect. Your physician helps you pick the molecule that fits your goals and history.

Free 4-minute intake. Physician review typically same business day. Pharmacy ships after approval. Most US addresses get the first month within 3–5 business days.

GLP-1s are notoriously hard to get covered for weight loss. We don't bill insurance, the cash price IS the price. HSA/FSA cards work. We'll send a superbill on request for your own reimbursement attempts.

Real: nausea (44%), constipation (24%), diarrhea (30%), fatigue early on. Manageable with slow titration and dietary adjustments. Rare: pancreatitis (<0.1%); severe abdominal pain means stop and go to ER. Gastroparesis (delayed gastric emptying) is the mechanism of the molecule, not a complication, but it can become symptomatic in a small number of members. Rare but monitored at every check-in.

Pharmacologically yes, but most members find their tolerance drops dramatically, sometimes to two drinks max. Many people find their relationship with alcohol shifts on GLP-1s, often in ways they're glad about.

Probably not. The FDA indication is BMI ≥30, or ≥27 with at least one comorbidity (hypertension, prediabetes, sleep apnea, dyslipidemia). We follow the indication. We'd rather refer than write the wrong script.

All three are common combinations and generally fine. Metformin pairs well with GLP-1s (often the doses can come down together). SSRIs are no contraindication. Thyroid: we monitor TSH because GLP-1s can change levothyroxine absorption.

Yes. Pause from your dashboard with one click. When you restart, you re-titrate from a lower dose to avoid the GI side effects. Your physician approves the re-start so we can review what's changed in the meantime.